Home > News > Mohan Bhandari receives Life-time Achievement Award
December 24th, 2007
Mohan Bhandari receives Life-time Achievement Award
Abstract:
Bilcare�s biggest contribution to the pharmaceutical industry so far, is the anti-counterfeit product. This product will help the pharmaceutical industry in securing their brand, increasing every product�s warranty and traceability, ensuring healthcare compliance and secure the supply management chain apart from eradicating counterfeit.
Out of major investments in nanotechnology research & development happening today, this is one of the first cost effective and useful solutions for the common man. The technology uses combination of new material with unique magnetic properties and proprietary pattern recognition in a cost effective way to mass manufacture identification tags. These nano-tags are virtually impossible to duplicate with inbuilt magnetic fingerprint technology, which can be read by specially developed magneto-optic readers. This data is then sent through a normal GPRS cell phone to the Central Server for instant secured authentication, which in turn identifies the pedigree of each product.
Source:
moneycontrol.com
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||